Lois Stepansky

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

Raj K. Maturi, Adam R. Glassman, Kristin Josic et al. · JAMA · 2023 · 60 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

Maureen G. Maguire, Danni Liu, Susan B. Bressler et al. · JAMA Ophthalmology · 2021 · 33 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema

David W. Hutton, Adam R. Glassman, Danni Liu et al. · JAMA Ophthalmology · 2023 · 24 citations · Full text

Medicine, Ophthalmology, Pharmacoeconomics +10

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

Ahmad A. Aref, Ingrid U. Scott, Paul VanVeldhuisen et al. · JAMA Ophthalmology · 2021 · 14 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15